-
Je něco špatně v tomto záznamu ?
Pathway to precision: machine learning and bioinformatics in diabetes gene expression studies
T. Aldaghi, A. Chrissan, J. Muzik, M. Rezaei-Tavirani, E. Nazari
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, přehledy
NLK
Open Access Digital Library
od 2012-01-01
Open Access Digital Library
od 2012-01-01
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
BACKGROUND: Diabetes mellitus is a metabolic disorder; understanding the pathogenic mechanisms underlying diabetes is crucial. Analyzing biomarkers, supported by machine learning and bioinformatics, is crucial for identifying the molecular causes of diabetes. OBJECTIVE: This study summarizes the current advances in diabetes research, highlighting significant progress in bioinformatics, gene expression analysis, and machine learning. METHODS: The search was conducted in Google Scholar, PubMed, and Scopus using two sets of keywords, including terms like diabetes, biomarkers, bioinformatics, and machine learning. The selection process followed PRISMA guidelines. The inclusion criteria targeted open-access English articles published from 2020 to 2024, resulting in a final selection of 96 articles. RESULTS: The findings were grouped into six categories: data acquisition methods, complications, bioinformatics techniques, machine learning methods, promotion, and evaluation. Microarrays were the most frequent technique for data collection, with 70 occurrences. The most common bioinformatics method was KEGG pathway analysis (84 instances). The most frequently used machine learning techniques were LASSO (43) and PCA (47). Prognostic applications were reported 45 times, while diagnostic applications appeared 51 times. CONCLUSION: Recent studies have highlighted the importance of KEGG pathway analysis and microarray datasets in diabetes research. Newer technologies, such as RNA-seq and single-cell RNA-seq, remain underutilized despite significant advancements in their development. A greater focus on novel biological pathways, the development of biomarkers, and a more comprehensive application of machine learning techniques could all aid in personalized treatment for diabetes. Future research should aim to overcome technological limitations and integrate clinical data with bioinformatics workflows to enhance translational relevance and promote precision medicine.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc26001537
- 003
- CZ-PrNML
- 005
- 20260122082550.0
- 007
- ta
- 008
- 260116s2026 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s40200-025-01814-2 $2 doi
- 035 __
- $a (PubMed)41424950
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Aldaghi, Tahmineh $u Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, Prague, Czech Republic
- 245 10
- $a Pathway to precision: machine learning and bioinformatics in diabetes gene expression studies / $c T. Aldaghi, A. Chrissan, J. Muzik, M. Rezaei-Tavirani, E. Nazari
- 520 9_
- $a BACKGROUND: Diabetes mellitus is a metabolic disorder; understanding the pathogenic mechanisms underlying diabetes is crucial. Analyzing biomarkers, supported by machine learning and bioinformatics, is crucial for identifying the molecular causes of diabetes. OBJECTIVE: This study summarizes the current advances in diabetes research, highlighting significant progress in bioinformatics, gene expression analysis, and machine learning. METHODS: The search was conducted in Google Scholar, PubMed, and Scopus using two sets of keywords, including terms like diabetes, biomarkers, bioinformatics, and machine learning. The selection process followed PRISMA guidelines. The inclusion criteria targeted open-access English articles published from 2020 to 2024, resulting in a final selection of 96 articles. RESULTS: The findings were grouped into six categories: data acquisition methods, complications, bioinformatics techniques, machine learning methods, promotion, and evaluation. Microarrays were the most frequent technique for data collection, with 70 occurrences. The most common bioinformatics method was KEGG pathway analysis (84 instances). The most frequently used machine learning techniques were LASSO (43) and PCA (47). Prognostic applications were reported 45 times, while diagnostic applications appeared 51 times. CONCLUSION: Recent studies have highlighted the importance of KEGG pathway analysis and microarray datasets in diabetes research. Newer technologies, such as RNA-seq and single-cell RNA-seq, remain underutilized despite significant advancements in their development. A greater focus on novel biological pathways, the development of biomarkers, and a more comprehensive application of machine learning techniques could all aid in personalized treatment for diabetes. Future research should aim to overcome technological limitations and integrate clinical data with bioinformatics workflows to enhance translational relevance and promote precision medicine.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Chrissan, Ashley $u Samueli School of Engineering, University of California, Los Angeles, Los Angeles, CA USA
- 700 1_
- $a Muzik, Jan $u Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Information and Communication Technologies in Medicine, Faculty of Biomedical Engineering, Czech Technical University, Prague, Czech Republic
- 700 1_
- $a Rezaei-Tavirani, Mostafa $u Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- 700 1_
- $a Nazari, Elham $u Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- 773 0_
- $w MED00217204 $t Journal of diabetes and metabolic disorders $x 2251-6581 $g Roč. 25, č. 1 (2026), s. 3
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/41424950 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20260116 $b ABA008
- 991 __
- $a 20260122082535 $b ABA008
- 999 __
- $a ok $b bmc $g 2470197 $s 1267254
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2026 $b 25 $c 1 $d 3 $e 20251217 $i 2251-6581 $m Journal of diabetes and metabolic disorders $n J Diabetes Metab Disord $x MED00217204
- LZP __
- $a Pubmed-20260116